Actionable
Commitment
We’re challenging ourselves, and others, to build a stronger focus on diversity, equity, and inclusion into our education and community engagement initiatives.
We’re challenging ourselves, and others, to build a stronger focus on diversity, equity, and inclusion into our education and community engagement initiatives.
Much progress has been made in primary biliary cholangitis (PBC) research and education, but the impact of race on PBC care and outcomes is not fully understood. Some Black, Indigenous and People of Color (BIPOC) patients with PBC describe experiences of not being seen and heard by their healthcare providers. In an effort to build awareness and dialogue around this complex issue, we convened a multidisciplinary panel of experts to review available data and share their perspectives both from the physician and patient point of view. Some questions we tackled include:
Exploring Racial Differences and Disparities in PBC Care
A roundtable discussion conducted in the U.S.
These slides include key epidemiology and outcomes data that you can use to enhance your educational presentations about PBC. Quotes from real patients living with PBC are also included.
This fact sheet can be printed as a flyer or distributed as a PDF via email. It includes key facts about racial disparities in PBC, insights from PBC experts and patient advocates, and a checklist to help primary care and other referring providers recognize the signs of symptoms of PBC in all races and ethnic backgrounds.
This template email can be used to help the primary care providers and other healthcare providers in your referral network to improve timely diagnosis of patients. It includes a simple checklist of symptoms and biochemical measures used to identify and diagnose PBC.
You are now leaving Intercept Pharmaceuticals’ corporate website and entering a site intended for U.S. audiences only.
You are now leaving Intercept Pharmaceuticals’ corporate website. Intercept does not control or endorse the content of this external site.
The link you have selected will take you outside of Intercept Pharmaceuticals’ corporate website.
The site you will be entering is intended for U.S. audiences only.
If you are a healthcare provider looking for product information, visit ocalivahcp.com.
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites.
Close this window to return to Intercept Pharmaceuticals’ site or click ‘Continue’ to proceed.
United States (US)
European Union (EU)
Canada
Israel
Switzerland
Australia
Liechtenstein
United Arab Emirates (UAE)
Exploring Racial Differences and Disparities in PBC Care